OCUL vs. REMX

Last updated Jun 4, 2026

OCUL (Ocular Therapeutix, Inc.) is a stock, while REMX (VanEck Vectors Rare Earth/Strategic Metals ETF) is Materials fund tracking the MVIS Global Rare Earth/Strategic Metals Index. Over the past 10 years, OCUL returned -3.44%/yr vs 10.14%/yr for REMX. At a 0.20 correlation, their price movements are largely independent.

Performance

OCUL vs. REMX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ocular Therapeutix, Inc. (OCUL) and VanEck Vectors Rare Earth/Strategic Metals ETF (REMX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, OCUL achieves a -31.22% return, which is significantly lower than REMX's 33.01% return. Over the past 10 years, OCUL has underperformed REMX with an annualized return of -3.44%, while REMX has yielded a comparatively higher 10.14% annualized return.

OCUL

• 1D: 0.48%
• 1M: -14.53%
• YTD: -31.22%
• 6M: -27.14%
• 1Y: 0.24%
• 3Y*: 6.46%
• 5Y*: -10.45%
• 10Y*: -3.44%

REMX

• 1D: -3.78%
• 1M: -3.72%
• YTD: 33.01%
• 6M: 37.14%
• 1Y: 172.35%
• 3Y*: 6.84%
• 5Y*: 4.50%
• 10Y*: 10.14%

*Multi-year figures are annualized to reflect compound growth (CAGR)

OCUL vs. REMX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
OCUL Ocular Therapeutix, Inc.	-31.22%	42.15%	91.48%	58.72%	-59.68%	-66.33%	424.05%	-0.75%	-10.56%	-46.83%
REMX VanEck Vectors Rare Earth/Strategic Metals ETF	33.01%	92.95%	-35.02%	-19.18%	-31.13%	79.81%	64.82%	0.74%	-49.63%	82.60%

Correlation

The correlation between OCUL and REMX is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.14
Correlation (3Y) Calculated over the trailing 3-year period	0.22
Correlation (5Y) Calculated over the trailing 5-year period	0.26
Correlation (10Y) Calculated over the trailing 10-year period	0.22
Correlation (All Time) Calculated using the full available price history since Jul 28, 2014	0.20

The correlation between OCUL and REMX shifts across timeframes, from 0.14 (1 year) to 0.26 (5 years), reflecting how their relationship changes across market environments.

Return for Risk

OCUL vs. REMX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OCUL

OCUL Risk / Return Rank: 41
OCUL Sharpe Ratio Rank: 40
OCUL Sortino Ratio Rank: 43
OCUL Omega Ratio Rank: 42
OCUL Calmar Ratio Rank: 40
OCUL Martin Ratio Rank: 40

REMX

REMX Risk / Return Rank: 87
REMX Sharpe Ratio Rank: 93
REMX Sortino Ratio Rank: 80
REMX Omega Ratio Rank: 75
REMX Calmar Ratio Rank: 94
REMX Martin Ratio Rank: 90

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

OCUL vs. REMX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Ocular Therapeutix, Inc. (OCUL) and VanEck Vectors Rare Earth/Strategic Metals ETF (REMX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	OCUL	REMX	Difference
Sharpe ratio: Return per unit of total volatility	0.00	3.61	-3.60
Sortino ratio: Return per unit of downside risk	0.56	3.66	-3.11
Omega ratio: Gain probability vs. loss probability	1.07	1.46	-0.39
Calmar ratio: Return relative to maximum drawdown	0.00	7.43	-7.42
Martin ratio: Return relative to average drawdown	0.01	21.32	-21.31
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

OCUL vs. REMX - Sharpe Ratio Comparison

The current OCUL Sharpe Ratio is 0.00, which is lower than the REMX Sharpe Ratio of 3.61. The chart below compares the historical Sharpe Ratios of OCUL and REMX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	OCUL	REMX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.00	3.61	-3.60
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.13	0.11	-0.25
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.04	0.28	-0.32
Sharpe Ratio (All Time) Calculated using the full available price history	-0.05	-0.08	+0.03

Drawdowns

OCUL vs. REMX - Drawdown Comparison

The maximum OCUL drawdown since its inception was -95.19%, which is greater than REMX's maximum drawdown of -90.20%. Use the drawdown chart below to compare losses from any high point for OCUL and REMX.

Drawdown Indicators

	OCUL	REMX	Difference
Max Drawdown Largest peak-to-trough decline	-95.19%	-90.20%	-4.99%
Max Drawdown (1Y) Largest decline over 1 year	-57.29%	-23.35%	-33.94%
Max Drawdown (3Y) Largest decline over 3 years	-72.77%	-62.11%	-10.66%
Max Drawdown (5Y) Largest decline over 5 years	-86.17%	-73.34%	-12.83%
Max Drawdown (10Y) Largest decline over 10 years	-90.94%	-73.34%	-17.60%
Current Drawdown Current decline from peak	-80.70%	-54.98%	-25.72%
Average Drawdown Average peak-to-trough decline	-76.62%	-66.87%	-9.75%
Ulcer Index Depth and duration of drawdowns from previous peaks	28.86%	8.12%	+20.74%

Volatility

OCUL vs. REMX - Volatility Comparison

Ocular Therapeutix, Inc. (OCUL) has a higher volatility of 16.12% compared to VanEck Vectors Rare Earth/Strategic Metals ETF (REMX) at 13.02%. This indicates that OCUL's price experiences larger fluctuations and is considered to be riskier than REMX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	OCUL	REMX	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.12%	13.02%	+3.10%
Volatility (6M) Calculated over the trailing 6-month period	59.66%	34.77%	+24.89%
Volatility (1Y) Calculated over the trailing 1-year period	69.33%	48.11%	+21.22%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	78.34%	40.24%	+38.10%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	79.92%	36.94%	+42.98%

Dividends

OCUL vs. REMX - Dividend Comparison

OCUL has not paid dividends to shareholders, while REMX's dividend yield for the trailing twelve months is around 1.32%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
OCUL Ocular Therapeutix, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
REMX VanEck Vectors Rare Earth/Strategic Metals ETF	1.32%	1.76%	2.56%	0.00%	1.56%	5.25%	0.81%	1.64%	12.43%	2.89%	2.23%	4.77%

Frequently Asked Questions

Can I hold both OCUL and REMX in my portfolio?

OCUL and REMX have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, OCUL or REMX?

OCUL has higher volatility (16.12%) compared to REMX (13.02%). In terms of maximum drawdown, OCUL dropped -95.19% vs REMX's -90.20%.

Which has better risk-adjusted returns?

REMX currently has the higher Sharpe Ratio (3.61 vs 0.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.